サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1409884

関節内補充療法の世界市場レポート 2024年

Viscosupplementation Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節内補充療法の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

関節内補充療法の市場規模は近年急速に拡大しています。2023年の37億4,000万米ドルから2024年には41億5,000万米ドルへと、CAGR11.0％で拡大します。歴史的な期間に観察された成長は、高齢化、肥満率の増加、保険適用の改善、個人の意識の高まり、患者の嗜好、変形性関節症に関連する症例の顕著な増加など、いくつかの要因に起因しています。これらの要素は、この期間の関節内補充療法治療の拡大と採用に総合的に貢献しました。

関節内補充療法市場の大手企業は、競争上の優位性を確保するために積極的に技術革新を進めています。その顕著な例が、カナダを拠点とする製薬会社Nuvo Pharmaceuticals Inc.で、同社は2021年1月にカナダ市場でNeoVisc+2mLとNeoVisc ONE 4mLを発売しました。これらの製品はヒアルロン酸（HA）粘液サプリメントで、一般的に変形性膝関節症に伴う膝の退行性関節症や機械的関節症の患者の疼痛緩和と関節機能強化のために特別に設計されたものです。NeoVisc+2mLとNeoVisc ONE 4mLの発売は、膝の痛みと変形性膝関節症に対する最先端の治療選択肢を提供するNuvo Pharmaceuticals Inc.の献身的な取り組みを強調するもので、カナダにおける関節内補充療法市場全体の成長に貢献しています。

北米は2023年の関節内補充療法市場において最大の地域でした。関節内補充療法市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 関節内補充療法市場の特徴

第3章 関節内補充療法市場の動向と戦略

第4章 関節内補充療法市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の関節内補充療法市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 関節内補充療法市場セグメンテーション

  • 世界の関節内補充療法市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 単回注入
  • 3回注入
  • 5回注入
  • 世界の関節内補充療法市場、由来別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 鳥類
  • 非鳥類
  • 世界の関節内補充療法市場、ヒアルロン酸別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 標準ヒアルロン酸
  • 安定化ヒアルロン酸
  • 世界の関節内補充療法市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 変形性膝関節症
  • 変形性股関節症
  • 変形性手関節症
  • 世界の関節内補充療法市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 外来手術センター
  • その他

第7章 関節内補充療法市場の地域別・国別分析

  • 世界の関節内補充療法市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の関節内補充療法市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の関節内補充療法市場

第9章 中国の関節内補充療法市場

第10章 インドの関節内補充療法市場

第11章 日本の関節内補充療法市場

第12章 オーストラリアの関節内補充療法市場

第13章 インドネシアの関節内補充療法市場

第14章 韓国の関節内補充療法市場

第15章 西欧の関節内補充療法市場

第16章 英国の関節内補充療法市場

第17章 ドイツの関節内補充療法市場

第18章 フランスの関節内補充療法市場

第19章 イタリアの関節内補充療法市場

第20章 スペインの関節内補充療法市場

第21章 東欧の関節内補充療法市場

第22章 ロシアの関節内補充療法市場

第23章 北米の関節内補充療法市場

第24章 米国の関節内補充療法市場

第25章 カナダの関節内補充療法市場

第26章 南米の関節内補充療法市場

第27章 ブラジルの関節内補充療法市場

第28章 中東の関節内補充療法市場

第29章 アフリカの関節内補充療法市場

第30章 競合情勢と企業プロファイル

  • 関節内補充療法市場の競合情勢
  • 関節内補充療法市場の企業プロファイル
    • Seikagaku Corporation
    • Anika Therapeutics Inc.
    • Bioventus LLC
    • Sanofi SA
    • Zimmer Biomet

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来展望と可能性分析

第35章 付録

目次
Product Code: r11422

“Viscosupplementation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The viscosupplementation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
  • 2) By Source: Avian Origin; Non-Avian Origin
  • 3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
  • 4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Sanofi S.A.; Zimmer Biomet
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Viscosupplementation involves the injection of hyaluronic acid gel directly into the joint to alleviate friction during movement. Hyaluronic acid, naturally present in synovial fluid surrounding joints, aids in reducing friction during joint motion.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection methods. Single-injection viscosupplementation entails a direct injection of hyaluronic acid into the knee's diarthrodial joints, restoring the synovial fluid's rheological properties to generate anti-inflammatory and analgesic effects. Hyaluronic acid variations such as standard and stabilized forms, sourced from avian and non-avian origins, are used to address various osteoarthritic conditions such as knee, hip, and hand osteoarthritis. These treatments are administered across diverse healthcare settings, including hospitals, ambulatory surgical centers, among others.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends, and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown rapidly in recent years. It will grow from $3.74 billion in 2023 to $4.15 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historic period can be attributed to several factors, including an aging population, increasing rates of obesity, improved insurance coverage, heightened awareness among individuals, patient preferences, and a notable rise in cases related to osteoarthritis. These elements collectively contributed to the expansion and adoption of viscosupplementation treatments during this period.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $6.19 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The projected growth in the upcoming period can be linked to several factors such as continued regulatory backing, the emergence of alternative payment structures, amplified healthcare expenditure, ongoing research and development efforts, and the widening of treatment applications. Key trends anticipated during this period encompass outcome-centric payment frameworks, initiatives focused on educating patients, advancements in biomarker development, ongoing exploration of gene therapy, and the implementation of value-based care models. These trends are expected to shape and drive the expansion of viscosupplementation practices in healthcare.

The increasing prevalence of osteoarthritis is poised to be a significant driver for the viscosupplementation market in the foreseeable future. Osteoarthritis, a degenerative joint disease and a common form of arthritis, manifests in the breakdown of joints, particularly in areas such as the hips, knees, and hands. Viscosupplementation treatment, involving the direct injection of hyaluronic acid into bone joints, serves to alleviate pain and enhance smooth bone movement. According to the Centers for Disease Control and Prevention (CDC), an American public health service organization, a projected 78.4 million adults aged 18 years and older in the USA are expected to be afflicted by arthritis by the year 2040. This underscores the pivotal role of the rising prevalence of osteoarthritis in propelling the growth trajectory of the viscosupplementation market.

Anticipated growth in healthcare expenditure is set to foster the expansion of the viscosupplementation market in the coming years. Healthcare expenditure, denoting the total spending on healthcare costs, encompasses the financial outlay on healthcare-related goods and services within a specific healthcare system or economy. The surge in healthcare expenditure plays a pivotal role in advancing the broader adoption and increased accessibility of viscosupplementation. This support extends to various aspects, including research, training, infrastructure development, and coverage by healthcare plans, ultimately benefiting individuals grappling with joint-related issues. As of November 2022, the Canadian Institute for Health Information, a U.S.-based not-for-profit organization, reported a notable increase in healthcare expenditure to 0.8%, reaching $331 billion in 2022, compared to 7.6% in 2021. Consequently, the upward trajectory of healthcare expenditure emerges as a driving force behind the growth of the viscosupplementation market.

The viscosupplementation market is witnessing a surge in popularity driven by advancements in technology. Companies within this market are strategically embracing new technologies to maintain their competitive edge. In August 2021, Seikagaku Corporation, a prominent Japanese pharmaceutical firm, unveiled HyLink, an innovative viscosupplement designed for intra-articular single injection to address knee osteoarthritis. HyLink incorporates cross-linking technology, a method used to create a long-lasting cross-linked hyaluronate hydrogel that effectively persists in the joint cavity, establishing it as a durable treatment solution. This move reflects Seikagaku Corporation's commitment to staying at the forefront of technological developments within the viscosupplementation sector.

Leading companies in the viscosupplementation market are actively pursuing innovation to secure a competitive advantage. A notable example is Nuvo Pharmaceuticals Inc., a Canada-based pharmaceutical company, which, in January 2021, introduced NeoVisc+ 2 mL and NeoVisc ONE 4 mL in the Canadian market. These products are hyaluronic acid (HA) viscosupplements specifically designed to address pain relief and enhance joint functionality in patients with degenerative or mechanical arthropathy of the knee, commonly associated with osteoarthritis. The launch of NeoVisc+ 2 mL and NeoVisc ONE 4 mL underscores Nuvo Pharmaceuticals Inc.'s dedication to delivering cutting-edge treatment options for knee pain and osteoarthritis, contributing to the overall growth of the viscosupplementation market in Canada.

In December 2021, Avanos Medical Inc., a medical technology company based in the United States, successfully completed the acquisition of OrthogenRx Inc. for a total transaction value of $160 million. This strategic move significantly expanded, diversified, and enhanced Avanos Medical Inc.'s chronic pain product portfolio, specifically by incorporating treatment options for individuals with knee osteoarthritis. The acquisition was strategically aligned with the company's objective to fortify its partnerships with healthcare providers on a global scale, particularly in the realm of musculoskeletal pain treatment. OrthogenRx Inc., a U.S.-based medical device company with expertise in viscosupplementation therapies for knee osteoarthritis, played a pivotal role in reinforcing Avanos Medical Inc.'s position in this therapeutic space.

Major companies operating in the viscosupplementation market report are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Sanofi S.A., Zimmer Biomet, Avanos Medical Inc., Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd., Merck KGaA, Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Wellchem Pharmaceuticals Pte Ltd., Chugai Pharmaceutical Corp., Laboratoires VIVACY, LG Life Sciences Ltd., Miravo Healthcare, Neopharmed Gentili S.p.A., SingHealth Group., Viatris, Allergan, Hoffmann-La Roche, Meda Pharmaceuticals, Merz Pharma, Mylan N.V., Novartis International AG .

North America was the largest region in the viscosupplementation market in 2023. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Viscosupplementation Market Characteristics

3. Viscosupplementation Market Trends And Strategies

4. Viscosupplementation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Viscosupplementation Market Size and Growth

  • 5.1. Global Viscosupplementation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Viscosupplementation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Viscosupplementation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Viscosupplementation Market Segmentation

  • 6.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation
  • 6.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Avian Origin
  • Non-Avian Origin
  • 6.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Standard Hyaluronic Acid
  • Stabilized Hyaluronic Acid
  • 6.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • 6.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

7. Viscosupplementation Market Regional And Country Analysis

  • 7.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Viscosupplementation Market

  • 8.1. Asia-Pacific Viscosupplementation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Viscosupplementation Market

  • 9.1. China Viscosupplementation Market Overview
  • 9.2. China Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Viscosupplementation Market

  • 10.1. India Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Viscosupplementation Market

  • 11.1. Japan Viscosupplementation Market Overview
  • 11.2. Japan Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Viscosupplementation Market

  • 12.1. Australia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Viscosupplementation Market

  • 13.1. Indonesia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Viscosupplementation Market

  • 14.1. South Korea Viscosupplementation Market Overview
  • 14.2. South Korea Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Viscosupplementation Market

  • 15.1. Western Europe Viscosupplementation Market Overview
  • 15.2. Western Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Viscosupplementation Market

  • 16.1. UK Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Viscosupplementation Market

  • 17.1. Germany Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Viscosupplementation Market

  • 18.1. France Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Viscosupplementation Market

  • 19.1. Italy Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Viscosupplementation Market

  • 20.1. Spain Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Viscosupplementation Market

  • 21.1. Eastern Europe Viscosupplementation Market Overview
  • 21.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Viscosupplementation Market

  • 22.1. Russia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Viscosupplementation Market

  • 23.1. North America Viscosupplementation Market Overview
  • 23.2. North America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Viscosupplementation Market

  • 24.1. USA Viscosupplementation Market Overview
  • 24.2. USA Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Viscosupplementation Market

  • 25.1. Canada Viscosupplementation Market Overview
  • 25.2. Canada Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Viscosupplementation Market

  • 26.1. South America Viscosupplementation Market Overview
  • 26.2. South America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Viscosupplementation Market

  • 27.1. Brazil Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Viscosupplementation Market

  • 28.1. Middle East Viscosupplementation Market Overview
  • 28.2. Middle East Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Viscosupplementation Market

  • 29.1. Africa Viscosupplementation Market Overview
  • 29.2. Africa Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Viscosupplementation Market Competitive Landscape And Company Profiles

  • 30.1. Viscosupplementation Market Competitive Landscape
  • 30.2. Viscosupplementation Market Company Profiles
    • 30.2.1. Seikagaku Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Anika Therapeutics Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bioventus LLC
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Zimmer Biomet
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Viscosupplementation Market Competitive Benchmarking

32. Global Viscosupplementation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Viscosupplementation Market

34. Viscosupplementation Market Future Outlook and Potential Analysis

  • 34.1 Viscosupplementation Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Viscosupplementation Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Viscosupplementation Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer